Generalized Anxiety Disorder Market Report 2026

Generalized Anxiety Disorder Market Overview

• Generalized Anxiety Disorder market size has reached to $7.93 billion in 2025 • Expected to grow to $9.72 billion in 2030 at a compound annual growth rate (CAGR) of 4.4% • Growth Driver: Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder Market • Market Trend: Innovative Drug Development Revolutionizes Generalized Anxiety Disorder Treatment • North America was the largest region in 2025.

What Is Covered Under Generalized Anxiety Disorder Market?

Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry, fear and anxiety about various aspects of life. It involves a broad range of concerns that can often feel uncontrollable and overwhelming. The treatment decisions change based on how significantly GAD is affecting a person's ability to function in daily life. The main types of generalized anxiety disorder are panic disorder, agoraphobia, generalized anxiety, social anxiety, specific phobia and others. Panic disorder refers to a mental health condition characterized by recurring and unexpected episodes of intense fear and discomfort known as panic attacks. It can be treated by various therapies, such as interpersonal therapy, behavior therapy, cognitive behavioral therapy and mindfulness-based cognitive therapy, by using different types of devices, including deep brain stimulation, electroconvulsive therapy, transcranial magnetic stimulation and vagus nerve stimulation. These are utilized by hospitals, homecare, specialty clinics and others.

What Is The Generalized Anxiety Disorder Market Growth Forecast?

The generalized anxiety disorder market size is expected to see steady growth in the next few years. It will grow to $9.72 billion in 2030 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to growth in digital therapeutics, demand for personalized mental healthcare, increased telehealth adoption, focus on preventive mental health, innovation in neuromodulation therapies. Major trends in the forecast period include rising adoption of cognitive behavioral therapy, increased use of pharmacological anxiety treatments, growth of digital mental health platforms, expansion of remote and telepsychiatry services, increased awareness of mental health disorders.

Global Generalized Anxiety Disorder Market Segmentation

1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types 2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy 3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation 4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Panic Disorder: Recurrent Panic Attacks, Unexpected Panic Attacks 2) By Agoraphobia: Situational Phobia, Open Spaces Anxiety 3) By Generalized Anxiety: Chronic Worry, Excessive Anxiety 4) By Social Anxiety: Performance Anxiety, Interaction Anxiety 5) By Specific Phobia: Animal Phobia, Environmental Phobia, Situational Phobia 6) By Other Type: Separation Anxiety Disorder, Selective Mutism, Post-Traumatic Stress Disorder (PTSD)

What Is The Driver Of The Generalized Anxiety Disorder Market?

The rising number of mental disorder cases in the healthcare industry is driving the growth of the generalized anxiety disorder market. A mental disorder, also known as a mental illness, refers to a wide range of conditions that affect a person's thoughts, emotions, behaviors and overall mental well-being. Mental health disorders that commonly occur with generalized anxiety disorder include phobias, panic disorder, post-traumatic stress disorder (PTSD) and obsessive-compulsive disorder (OCD) and managing these conditions is crucial for individuals to maintain healthy relationships and improve their quality of life. For instance, in November 2023, according to Stress in America 2023 survey published by American Psychological Association, a US-based professional organization, adults aged 35 to 44 experienced the highest increase in mental health diagnoses, 45% reported a mental illness in 2023 compared with 31%. However, adults ages 18 to 34 still reported the highest rate of mental illnesses at 50% in 2023. Therefore, the rising number of mental disorder cases is expected to propel the growth of the generalized anxiety disorder industry.

Key Players In The Global Generalized Anxiety Disorder Market

Major companies operating in the generalized anxiety disorder market are Alkermes plc, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline plc, Johnson And Johnson Private Limited, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Mind Medicine Inc., Sage Therapeutics Inc., VistaGen Therapeutics Inc.

Global Generalized Anxiety Disorder Market Trends and Insights

Major companies operating in the generalized anxiety disorder market are developing innovative drugs such as MM-120 and getting approval for the treatment of generalized anxiety disorder to better meet the needs of their existing consumers. Innovative drugs such as MM-120 aim to improve the management and outcomes of this mental health condition. For instance, in September 2023, Mind Medicine Inc. (MindMed), a U.S.-based biotech company focused on psychedelic-inspired therapies, completed enrollment in its Phase 2b trial of MM 120 (lysergide D-tartrate) for generalized anxiety disorder (GAD). With this milestone, MindMed aims to generate robust efficacy and safety data to support further development of MM 120 as a novel treatment option for GAD. MM 120 is a small-molecule partial agonist of the 5 HT₂A receptor, designed to enhance neuroplasticity and serotonin signaling to improve mood and anxiety, and it showed a dose dependent reduction in anxiety symptoms in the trial.

What Are Latest Mergers And Acquisitions In The Generalized Anxiety Disorder Market?

In July 2023, Big Health, a US-based digital therapeutics company, acquired Limbix Health Inc. for an undisclosed amount. With this acquisition, Big Health aims to make a strategic move that will allow the two companies to combine their expertise and resources to develop and deliver more effective digital therapeutics for mental health conditions. Limbix Health Inc. is a US-based digital therapeutics platform that provides mental health treatment for young people suffering from depression, anxiety and other mental illnesses.

Regional Outlook

North America was the largest region in the generalized anxiety disorder market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Generalized Anxiety Disorder Market?

The generalized anxiety disorder market consists of revenues earned by entities by providing services such as exposure therapy, supportive psychotherapy, relaxation therapies, group therapy, stress management and self-care practices. The market value includes the value of related goods sold by the service provider or included within the service offering. The generalized anxiety disorder market also includes sales of pregabalin, hydroxyzine, beta-blockers, atypical antipsychotics and alprazolam. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Generalized Anxiety Disorder Market Report 2026?

The generalized anxiety disorder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the generalized anxiety disorder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.